Roffman Miller Associates Inc. PA Sells 6,532 Shares of Cigna Group $CI

Key Points

• Roffman Miller Associates trimmed its stake in Cigna by 9.9%, selling 6,532 shares in Q4 and leaving 59,444 shares valued at about $16.36 million.
• Cigna beat Q4 expectations with EPS of $8.08 vs. $7.88 expected and revenue of $72.5 billion, and the company set FY‑2026 guidance at 30.250 EPS (consensus ~29.77).
• Cigna raised its quarterly dividend to $1.56 ($6.24 annually, a 2.2% yield), while insiders including Nicole S. Jones and Everett Neville disclosed notable share sales that reduced their positions.

Roffman Miller Associates Inc. PA cut its holdings in Cigna Group (NYSE:CI - Free Report) by 9.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 59,444 shares of the health services provider's stock after selling 6,532 shares during the period. Roffman Miller Associates Inc. PA's holdings in Cigna Group were worth $16,361,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Harbor Capital Advisors Inc. lifted its stake in shares of Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider's stock valued at $26,000 after buying an additional 49 shares during the period. Beacon Financial Strategies CORP bought a new stake in shares of Cigna Group in the fourth quarter valued at about $28,000. Lodestone Wealth Management LLC bought a new stake in shares of Cigna Group in the fourth quarter valued at about $32,000. Collier Financial bought a new stake in shares of Cigna Group in the third quarter valued at about $34,000. Finally, True Wealth Design LLC lifted its stake in shares of Cigna Group by 116.4% in the fourth quarter. True Wealth Design LLC now owns 158 shares of the health services provider's stock valued at $43,000 after buying an additional 85 shares during the period. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Stock Performance

NYSE:CI opened at $278.27 on Friday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The firm has a 50 day moving average of $276.40 and a 200-day moving average of $278.75. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $73.33 billion, a P/E ratio of 12.55, a price-to-earnings-growth ratio of 0.96 and a beta of 0.26.

Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion during the quarter, compared to analysts' expectations of $69.53 billion. During the same quarter in the previous year, the company posted $6.64 earnings per share. Cigna Group's quarterly revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th were paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. This is an increase from Cigna Group's previous quarterly dividend of $1.51. The ex-dividend date was Thursday, March 5th. Cigna Group's dividend payout ratio is presently 28.13%.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 2,307 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares in the company, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Everett Neville sold 1,719 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares of the company's stock, valued at $1,638,119.70. This trade represents a 23.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.60% of the company's stock.

Analyst Upgrades and Downgrades

CI has been the subject of several research reports. Deutsche Bank Aktiengesellschaft increased their target price on shares of Cigna Group from $301.00 to $304.00 and gave the company a "buy" rating in a research note on Tuesday, February 10th. Robert W. Baird reduced their target price on shares of Cigna Group from $372.00 to $315.00 and set an "outperform" rating for the company in a research note on Thursday, December 11th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Cigna Group in a research note on Monday, December 29th. Royal Bank Of Canada reduced their target price on shares of Cigna Group from $344.00 to $333.00 and set an "outperform" rating for the company in a research note on Friday, February 6th. Finally, Wall Street Zen upgraded shares of Cigna Group from a "hold" rating to a "buy" rating in a research note on Saturday, February 7th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $333.11.

Cigna Group Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.